• About us
  • People
  • Expertise
    • Sectors
        • Technology, media & communications Technology, media & communications
        • Private Wealth Private wealth
        • Real estate, infrastructure & energy
        • Life sciences & healthcare icon Life sciences & healthcare
        • Aerospace & defence
        • Automotive & mobility
        • Business & professional services
        • Chemicals
        • Consumer & retail
        • Financial institutions & insurance
        • Hotels, hospitality & leisure
        • Logistics & transport
        • Manufacturing & industrials
        • Public services & education
    • Legal services
        • Artificial intelligence
        • Banking & finance
        • Brands & advertising
        • Commercial & consumer contracts
        • Competition, EU & trade
        • Copyright & media law
        • Corporate crime & compliance
        • Corporate/M&A & capital markets
        • Data & cyber
        • Disputes & investigations
        • Employment, pensions & mobility
        • Environmental, planning & regulatory
        • Environmental, social & governance (ESG)
        • Intellectual property
        • Information technology
        • Patents & innovation
        • Private client
        • Private equity
        • Projects, energy & infrastructure
        • Real estate & construction
        • Regulation
        • Restructuring & insolvency
        • Tax
        • Venture capital
  • Locations
    • Europe
        • Locations
        • Austria
        • Belgium
        • Czech Republic
        • France
        • Germany
        • Hungary
        • Italy
        • Netherlands
        • Poland
        • Portugal
        • Ireland
        • Slovakia
        • Spain
        • United Kingdom
        • Ukraine
          Groups & regions
        • CEE Turkish Desk
        • French German group
        • Our offices
    • Middle East & Africa
        • Locations
        • Middle East
        • UAE
          Groups
        • Africa group
        • Israel group
        • Our offices
    • Americas
        • Locations
        • Latin America
        • USA
          Groups
        • Brazil group
        • Our offices
    • Asia
        • Locations
        • Asia
        • China
        • South Korea
          Groups
        • India group
        • Japan group
        • Our offices
  • Insights
    • Insights
        • Featured Topics
        • Artificial intelligence
        • Data Centre Expertise
        • The EU Whistleblower Directive
        • German Supply Chain Act
        • Unified Patent Court
          Content hub
        • Global Data Hub
        • Interface: tech, IP and media law
        • Podcasts
        • Synapse
        • Browse all insights
    • In focus
        • AI
        • Dealonomics
        • Disputes
        • Intellectual property
        • MENA
        • Regulation
        • Browse in focus
    • Events
        • In person
        • Online
        • Browse all events
    • News
        • Media centre
        • Work highlights
        • Firm news
        • Browse all news
  • Careers
  • EN
    • English
    • 中文(简体)
    • Français
    • Deutsch
  • Home
  • People
  • Meg Burton
Meg Burton
Meg Burton

Meg Burton

Senior Counsel

  • London UK
  • San Francisco USA
Contact Me Today
+44 20 7300 7000
vCard
Email me Call me

Meg specialises in US corporate and securities law, advising on, among other things, general corporate matters and venture capital financing transactions, particularly in the life sciences sector. 

Meg's day-to-day work focuses on advising life sciences and technology companies at all stages of development, with a particular focus on advising both companies and investors in venture capital financing transactions, from early-stage to late-stage. She also works closely with entrepreneurs to counsel them through initial company formation issues, day-to-day corporate governance matters, and liquidity events.

Prior to joining Taylor Wessing, she spent ten years at a top-tier firm in California, where she represented prominent US and international companies and funds in life sciences and technology financing transactions and exits. She is a current member of the California Bar.

Meg particularly enjoys advising clients on complex US and cross-border venture financing transactions.

Expertise

Services and Groups

Venture capital
Corporate/M&A & capital markets
General corporate
M&A
Financing rounds (Seed, subsequent and growth financing) equity and non-equity instruments
Start-up advice

Sectors

Life sciences & healthcare
Biotech
Life sciences start-ups and investors
Medical devices
Pharmaceuticals
Our USA offering

Over the past 10 years, we've built a trusted legal team in San Francisco, focused on technology, media and communciation, life sciences and healthcare, real estate, private wealth, and private equity. Supported by colleagues in the UK and Europe, we also offer deep expertise in M&A, international growth, commercial deals, and data privacy.

Find out more

CV

Since 2024 Senior Counsel, Taylor Wessing
2014 - 2024 Associate, Wilson Sonsini Goodrich & Rosati, PC, San Diego, California, USA
2014 Admission to bar, California, USA
2013 Juris Doctor, Indiana University Maurer School of Law, Bloomington, IN, USA
2010 Bachelor of Science, Clemson University, Clemson, SC, USA

Career

Since 2024 Senior Counsel, Taylor Wessing
2014 - 2024 Associate, Wilson Sonsini Goodrich & Rosati, PC, San Diego, California, USA

Education

2014 Admission to bar, California, USA
2013 Juris Doctor, Indiana University Maurer School of Law, Bloomington, IN, USA
2010 Bachelor of Science, Clemson University, Clemson, SC, USA

Experience

Series B fundraising of USD100+ million

Represented client utilizing a generated AI discovery platform in oversubscribed financing round with multiple strategic and institutional investors

Meg Burton

Series C fundraising of USD200 million

Represented U.S. medical imaging software and device company in late-stage financing round

Meg Burton

Meg's news & insights

View Meg's insights
Suspension bridge
Click here to find out more
Corporate/M&A & capital markets

Advising Waivgen on its acquisition by Synechron

21 October 2025

by multiple authors

Glass.Mapper.Sc.Fields.Image?.Alt
Artificial intelligence

Advising Artificial Societies on Pre-Seed and Seed funding rounds

3 September 2025

by multiple authors

Click here to find out more
Glass.Mapper.Sc.Fields.Image?.Alt
Life sciences & healthcare

Reporting clinical trial results to the market

25 October 2024
Quick read

by multiple authors

Click here to find out more
View Meg's insights

Related news & insights

Different coloured abacus
Tax

Strengthening our Real Estate Sector capabilities with appointment of tax expert Gemma Grunewald

4 March 2026

by multiple authors

Click here to find out more
Environmental, social & governance (ESG)

UK Sustainability Reporting Standards – what you need to know

3 March 2026
Briefing

by multiple authors

Click here to find out more
Search Result Streets
Corporate/M&A & capital markets

Amendments to the Commercial Code

2 March 2026
In-depth analysis

by Juraj Frindrich, LL.M. and Milan Červenka, LL.M.

Click here to find out more
Skyline view of traffic
Corporate/M&A & capital markets

Advising Verdane on recommended cash offer for Augmentum Fintech plc

27 February 2026

by multiple authors

Click here to find out more
Close-Up Of Modern Office Facade
Banking & finance

Creating new investment vehicle as part of first-ever PISCES share sale

26 February 2026

by multiple authors

Click here to find out more
Blood samples
Pharmaceuticals

Biopharma partnering update: Q4 2025

25 February 2026
Quick read

by multiple authors

Click here to find out more
Triangles
Corporate/M&A & capital markets

Taylor Wessing advises JD Group on the sale of optek-Danulat to Crane Co.

25 February 2026

by multiple authors

Click here to find out more
Close-Up Of Modern Office Facade
Corporate/M&A & capital markets

Advising proptech platform Stake on its US$31 million Series B round

24 February 2026

by multiple authors

Click here to find out more
Patterned pills
Life sciences & healthcare

Reform of the MDR and IVDR – A critical look at the Commission's proposal of 16 December 2025

19 February 2026
In-depth analysis

by Dr. Wolfgang Rehmann

Click here to find out more
Search Result Thumbnail Crypto
Corporate/M&A & capital markets

Clearer rules on cryptocurrency trading

19 February 2026
Briefing

by Ákos Mátés-Lányi, LL.M., MRICS

Click here to find out more
View all insights

Related people

UK
Global
Emma Danks

Emma Danks

Partner

London
+44 20 7300 4718
Email me
View profile
Rachael Potts

Rachael Roberts

Associate

London
+44 20 7300 7000
Email me
View profile

Chris Cowley

Partner

London
+44 20 7300 7189
Email me
View profile
Will Belcher

William Belcher

Partner

London
+44 20 7300 4221
Email me
View profile
Tom Charnley

Tom Charnley

Senior Counsel

Liverpool
London
+44 20 7300 7000
Email me
View profile
Paul Thorpe

Paul Thorpe

Partner

London
+44 20 7300 4111
Email me
View profile
Dillan Madhani

Dillan Madhani

Associate

London
+44 20 7300 7000
Email me
View profile

Andrew Edge

Partner

London
+44 20 7300 7037
Email me
View profile
Nell Cooper

Nell Cooper

Senior Associate

London
+44 20 7300 7000
Email me
View profile
Tunc Ilgin

Tunç Ilgin

Senior Associate

London
+44 20 7300 7000
Email me
View profile
Full team
Ed Chapman

Ed Chapman

Partner

London
+44 20 7300 7014
Email me
View profile
Christopher Peine

Christopher Peine

Salary Partner

Frankfurt
+49 69 97130 0
Email me
View profile
fritz krings

Fritz Krings

Salary Partner

Munich
+49 160 95 509 250
Email me
View profile
Tunc Ilgin

Tunç Ilgin

Senior Associate

London
+44 20 7300 7000
Email me
View profile

Dr. Ralf B. Tietz, LL.M. (Chicago)

Salary Partner

Berlin
+49 30 885636 165
Email me
View profile
Bella Clark-Thornton

Bella Thornton-Clark

Senior Associate

London
San Francisco
+44 20 7300 7000
Email me
View profile
Gilles Amsallem

Gilles Amsallem

Partner

Paris
+33 172 74 03 10
Email me
View profile
Will Belcher

William Belcher

Partner

London
+44 20 7300 4221
Email me
View profile
Antony Jonkman

Antony Jonkman

Partner

Amsterdam
+31 88 024 3195
Email me
View profile
François Mary

François Mary

Partner

Paris
+33 1 72 74 03 24
Email me
View profile
Full team

Meet me at

There are no upcoming events

See all events
Subscribe to our latest insights
  • About us
  • Campaigns and online tools
  • News
  • People
  • Expertise
  • Locations
  • Insights
  • Events
  • Media centre
  • Contact
  • Careers
  • Alumni
  • Data protection & privacy policy
  • Cookie policy
  • Legal and regulatory information
  • Regulatory information on costs
  • Complaints procedure for clients
  • Terms of use
  • Anti-slavery statement
  • Environmental
  • Scam emails

© Taylor Wessing